Company intelligence / Profile preview

Virustatic

United Kingdom

Ownership: Private
Employees: ~3
Development stage: Other

Overview

Virustatic SHIELD® is an award-winning innovation in viral filtration technology, a breathable face covering with patented Viruferrin® coating providing natural aerosol filtration and 360-degree protection.[2][8] The product is the result of 12 years of research and development into pandemic prevention.[2]

Therapeutic areas: Women's HealthOtherInfectious Diseases
Modalities: ProteinDevice
Industry: Consumable Medical Devices

Partnerships

University of Leeds (R&D collaboration on Viruferrin® coating development)[2]University of the Arts London (UAL) (R&D collaboration on sustainable textile coatings)[2]University of Bradford (partnership on drug delivery methods for feminine health applications)[7]

Beyond the preview

Go deeper on Virustatic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Virustatic.

Explore the full profile